Charles Sinclair

Publication Activity (10 Years)

Years Active: 2017-2022
Publications (10 Years): 4

Top Topics

Dna Damage Response

Dendritic Cells

Chronic Rhinosinusitis

Top Venues

EMBO molecular medicine

Science (New York, N.Y.)

Emerging topics in life sciences

This page only lists publications with an associated author ORCID identifier.

Publications

Elizabeth A Kuczynski, Giulia Morlino, Alison Peter, Anna M L Coenen-Stass, Jennifer I Moss, Neha Wali, Oona Delpuech, Avinash Reddy, Anisha Solanki, Charles Sinclair, Dinis Pedro Calado, Larissa S Carnevalli
A preclinical model of peripheral T-cell lymphoma GATA3 reveals DNA damage response pathway vulnerability. EMBO molecular medicine 14 (6) (2022)
Jaclyn Sceneay, Charles Sinclair
The future of immune checkpoint combinations with tumor-targeted small molecule drugs. Emerging topics in life sciences 5 (5) (2022)
Sophie Langdon, Adina M Hughes, Molly Ann Taylor, Elizabeth A Kuczynski, Deanna A Mele, Oona Delpuech, Laura Jarvis, Anna Staniszewska, Sabina Cosulich, Larissa S Carnevalli, Charles Sinclair
Combination of dual mTORC1/2 inhibition and immune-checkpoint blockade potentiates anti-tumour immunity. Oncoimmunology 7 (8) (2018)
Charles Sinclair, Gayathri Bommakanti, Luiz Gustavo Gardinassi, Jens Loebbermann, Matthew Joseph Johnson, Paul Hakimpour, Thomas Hagan, Lydia Benitez, Andrei Todor, Deepa Machiah, Timothy Oriss, Anuradha Ray, Steven Bosinger, Rajesh Ravindran, Shuzhao Li, Bali Pulendran
mTOR regulates metabolic adaptation of APCs in the lung and controls the outcome of allergic inflammation. Science (New York, N.Y.) 357 (6355) (2017)